| Lenscrafters#00490 | |
| 6401 Bluebonnet Blvd, Ste 5050, Baton Rouge, Louisiana 70836 | |
| (225) 766-9907 |
| Name | Lenscrafters#00490 |
|---|---|
| Organization Name | Luxottica Of America Inc |
| Location | 6401 Bluebonnet Blvd, Ste 5050, Baton Rouge, Louisiana 70836 |
| Type | Eyewear Supplier (Equipment, not the service) |
| Phone | (225) 766-9907 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Reflecting the changing economic landscape, more older workers are staying in the work force, but increasingly in part-time rather than full-time jobs, according to new research released today by the nonpartisan Employee Benefit Research Institute (EBRI).
The U.S. Food and Drug Administration is tightening the potency specifications for levothyroxine sodium, used to treat underactive thyroid glands and other thyroid conditions, to ensure the drug retains its potency over its entire shelf life.
Scientists from UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research are bringing stem cell science funded by the California Institute of Regenerative Medicine (CIRM), the state stem cell agency, directly to patients in two exciting new clinical trials scheduled to begin in early 2014.
Trending at offices are standing desks that allows the user to stand for longer hours in an attempt to reduce sedentary time. While sitting for a long period of time is not a good idea, a new study finds that standing for long hours may not be good for health either.
Valeant Pharmaceuticals International, Inc. today announced that that its wholly owned subsidiary, Valeant Pharmaceuticals North America LLC, received notice that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Jublia® (efinaconazole 10% topical solution), the first topical triazole approved for the treatment of onychomycosis of the toenails.
› Verified 7 days ago
| NPI Number | 1346395753 |
| Organization Name | LUXOTTICA OF AMERICA INC. |
| Doing Business As | LENSCRAFTERS #490 |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 6401 Bluebonnet Blvd Ste 5050, Baton Rouge, LA 70836 |
| Phone Number | 225-766-9907 |
News Archive
Reflecting the changing economic landscape, more older workers are staying in the work force, but increasingly in part-time rather than full-time jobs, according to new research released today by the nonpartisan Employee Benefit Research Institute (EBRI).
The U.S. Food and Drug Administration is tightening the potency specifications for levothyroxine sodium, used to treat underactive thyroid glands and other thyroid conditions, to ensure the drug retains its potency over its entire shelf life.
Scientists from UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research are bringing stem cell science funded by the California Institute of Regenerative Medicine (CIRM), the state stem cell agency, directly to patients in two exciting new clinical trials scheduled to begin in early 2014.
Trending at offices are standing desks that allows the user to stand for longer hours in an attempt to reduce sedentary time. While sitting for a long period of time is not a good idea, a new study finds that standing for long hours may not be good for health either.
Valeant Pharmaceuticals International, Inc. today announced that that its wholly owned subsidiary, Valeant Pharmaceuticals North America LLC, received notice that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Jublia® (efinaconazole 10% topical solution), the first topical triazole approved for the treatment of onychomycosis of the toenails.
› Verified 7 days ago
| NPI Number | 1669130639 |
| Organization Name | LUXOTTICA OF AMERICA INC |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 6401 Bluebonnet Blvd Ste 1088, Baton Rouge, LA 70836 |
| Phone Number | 225-819-1220 |
News Archive
Reflecting the changing economic landscape, more older workers are staying in the work force, but increasingly in part-time rather than full-time jobs, according to new research released today by the nonpartisan Employee Benefit Research Institute (EBRI).
The U.S. Food and Drug Administration is tightening the potency specifications for levothyroxine sodium, used to treat underactive thyroid glands and other thyroid conditions, to ensure the drug retains its potency over its entire shelf life.
Scientists from UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research are bringing stem cell science funded by the California Institute of Regenerative Medicine (CIRM), the state stem cell agency, directly to patients in two exciting new clinical trials scheduled to begin in early 2014.
Trending at offices are standing desks that allows the user to stand for longer hours in an attempt to reduce sedentary time. While sitting for a long period of time is not a good idea, a new study finds that standing for long hours may not be good for health either.
Valeant Pharmaceuticals International, Inc. today announced that that its wholly owned subsidiary, Valeant Pharmaceuticals North America LLC, received notice that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Jublia® (efinaconazole 10% topical solution), the first topical triazole approved for the treatment of onychomycosis of the toenails.
› Verified 7 days ago
News Archive
Reflecting the changing economic landscape, more older workers are staying in the work force, but increasingly in part-time rather than full-time jobs, according to new research released today by the nonpartisan Employee Benefit Research Institute (EBRI).
The U.S. Food and Drug Administration is tightening the potency specifications for levothyroxine sodium, used to treat underactive thyroid glands and other thyroid conditions, to ensure the drug retains its potency over its entire shelf life.
Scientists from UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research are bringing stem cell science funded by the California Institute of Regenerative Medicine (CIRM), the state stem cell agency, directly to patients in two exciting new clinical trials scheduled to begin in early 2014.
Trending at offices are standing desks that allows the user to stand for longer hours in an attempt to reduce sedentary time. While sitting for a long period of time is not a good idea, a new study finds that standing for long hours may not be good for health either.
Valeant Pharmaceuticals International, Inc. today announced that that its wholly owned subsidiary, Valeant Pharmaceuticals North America LLC, received notice that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Jublia® (efinaconazole 10% topical solution), the first topical triazole approved for the treatment of onychomycosis of the toenails.
› Verified 7 days ago
Action Rehab And Supply Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1443 Delplaza Dr, Baton Rouge, Louisiana 70815 Phone: (225) 214-1260 | |
Aids Healthcare Foundation Type: Community/Retail Pharmacy Location: 4890 Bluebonnet Blvd, Baton Rouge, Louisiana 70809 Phone: (225) 297-4430 | |
Sav On Pharmacy #3792 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 9960 Bluebonnet Blvd, Baton Rouge, Louisiana 70810 Phone: (225) 768-7950 | |
Sav-on Pharmacy #0709 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2950 College Dr, Baton Rouge, Louisiana 70808 Phone: (225) 924-6094 | |
Sav-on Pharmacy #0712 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 9650 Airline Hwy, Baton Rouge, Louisiana 70815 Phone: (225) 926-9604 |